SI
APLT

Sofinnova Investments’s Applied Therapeutics APLT Stock Holding History

Sofinnova Investments’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-134,825
Closed -$3.68M – 65
2019
Q4 		$3.68M Sell
134,825
-7,179
-5% -$123K 0.27% 49
2019
Q3 		$1.56M Hold
142,004
– – 0.14% 63
2019
Q2 		$1.17M Buy
+142,004
New +$1.34M 0.11% 67

Other funds holding APLT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sofinnova Investments's APLT Position: Q1 2020 in Review

Sofinnova Investments sold out of Applied Therapeutics (APLT) in Q1 2020, closing a stake of 134,825 shares — an estimated $3.68M sold.

Sofinnova Investments first reported a position in APLT in Q2 2019 and held it in 3 quarters. The position peaked at $3.68M in Q4 2019. 64 funds tracked by Wall St. Rank hold APLT as of Q1 2020.

  • Sofinnova Investments reported no remaining Applied Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Sofinnova Investments sold 134,825 Applied Therapeutics shares in Q1 2020, an estimated $3.68M.
  • Sofinnova Investments first reported a position in Applied Therapeutics in Q2 2019 and held it in 3 quarters.
  • Sofinnova Investments's Applied Therapeutics position peaked at $3.68M in Q4 2019.
  • 64 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2020.

Based on Sofinnova Investments's 13F filing for Q1 2020, filed 13 May 2020.